Category: Manufacturing

October 30, 2020

AB2 Bio, a Swiss clinical-stage biotech company developing therapies for the treatment of severe systemic autoinflammatory diseases, and WuXi Biologics agreed to collaborate to set up and accelerate commercial-scale manufacturing of Tadekinig alfa, AB2 Bio’s recombinant IL-18 binding protein. AB2 […]

October 27, 2020

Medigene, clinical stage immuno-oncology company focusing on the development of T cell immunotherapies for cancer, entered into a service agreement with Cytovant Sciences to support process development activities for the manufacturing of dendritic cell (DC) vaccines. The deal builds on […]

October 20, 2020

CNS Pharmaceuticals Inc.’s U.S. manufacturer, Pharmaceutics International Inc., has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable. “Completing the manufacturing […]

October 16, 2020

Tissues in the body work as a complex team of interconnected cells. For instance, the heart is comprised of contractile cardiomyocytes, along with a vast array of endothelial cells, immune cells and fibroblasts. Similarly, the liver includes hepatocytes, immune cells, […]

October 12, 2020

CDMO Abzena is poised for massive growth with the completion of its new $60 million facility for Phase III and commercial cGMP manufacturing. The 50,000 sqft “Lusk” facility is a welcome addition to the company’s San Diego, CA site, allowing […]

October 9, 2020

CNS PHARMACEUTICALS AG, (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the Company’s European manufacturer, BSP Pharmaceuticals […]

October 9, 2020

Rentschler Biopharma agreed to serve as CDMO partner for BioNTech whereby Rentschler Biopharma will be responsible for key aspects of cGMP drug substance manufacturing of BNT162b2, the mRNA-based vaccine against SARS-CoV-2 that is being developed by Pfizer and BioNTech, and […]

September 29, 2020

For far too long, cell culture experiments lacked dimensionality and not abstractly, but in the actual physical sense. Scientists were forced to grow their cells in only two dimensions, creating monolayers that are unrepresentative of true in vivo conditions. But […]

September 28, 2020

Inovio has benefited from having a head start on many other coronavirus vaccine manufacturers. It was one of the first to begin human safety studies, an event that has helped to buoy its shares this year — even with Monday’s […]

September 24, 2020

Officials at Catalent, a CDMO, recently announced plans for a new gene therapy facility, explaining that the $130 million expansion will add five Phase III through commercial-scale manufacturing suites. The plant will make extensive use of automation according to Randy […]

September 23, 2020

Samsung Biologics and AstraZeneca announced on Monday that they have entered a long-term supply agreement, expected to be valued at approximately $330 million. Under the new deal, Samsung Biologics will offer large-scale commercial manufacturing for drug substance in its Plant […]

September 15, 2020

When asked about the biggest challenge in today’s bioprocessing, Sandy Williams, PhD, a biomedical engineering expert at Scientific Bioprocessing (SBI) in Pittsburgh who focuses on regenerative medicine, says, “The biggest concern we have heard from the industry is that bioprocessing […]